ATE540684T1 - Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina - Google Patents

Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina

Info

Publication number
ATE540684T1
ATE540684T1 AT06741747T AT06741747T ATE540684T1 AT E540684 T1 ATE540684 T1 AT E540684T1 AT 06741747 T AT06741747 T AT 06741747T AT 06741747 T AT06741747 T AT 06741747T AT E540684 T1 ATE540684 T1 AT E540684T1
Authority
AT
Austria
Prior art keywords
vaginal
vagina
regulating
preparation
bacterial flora
Prior art date
Application number
AT06741747T
Other languages
English (en)
Inventor
Zhongming Zeng
Ruyun Zhou
Original Assignee
Shenzhen Phlora Biotechnology Ltd
Hk Phlora Health Sci & Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Phlora Biotechnology Ltd, Hk Phlora Health Sci & Tech Ltd filed Critical Shenzhen Phlora Biotechnology Ltd
Application granted granted Critical
Publication of ATE540684T1 publication Critical patent/ATE540684T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06741747T 2005-04-27 2006-04-27 Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina ATE540684T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510070307 2005-04-27
PCT/CN2006/000826 WO2006114061A1 (en) 2005-04-27 2006-04-27 A composition and method of regulating and maintaining the vaginal bacterial flora and the normal acidity in the vaginal

Publications (1)

Publication Number Publication Date
ATE540684T1 true ATE540684T1 (de) 2012-01-15

Family

ID=37214419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06741747T ATE540684T1 (de) 2005-04-27 2006-04-27 Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina

Country Status (9)

Country Link
US (2) US20080193428A1 (de)
EP (1) EP1911454B1 (de)
JP (1) JP5065246B2 (de)
CN (1) CN101175503B (de)
AT (1) ATE540684T1 (de)
BR (1) BRPI0612968A2 (de)
CA (1) CA2609754C (de)
RU (1) RU2409368C2 (de)
WO (1) WO2006114061A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69812595T2 (de) * 1997-12-12 2003-09-25 Mitsubishi Heavy Industries, Ltd. Walzvorrichtung und walzverfahren
CN109010900A (zh) * 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
CN101657221A (zh) 2006-11-17 2010-02-24 Sca卫生用品公司 包含微生物抑制性组合物的卫生用品
US20090185995A1 (en) * 2008-01-18 2009-07-23 Stacy Vochecowicz Lubricious, non-tacky personal lubricant
IT1398279B1 (it) * 2009-06-25 2013-02-22 Bsd Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
WO2011041938A1 (zh) * 2009-10-08 2011-04-14 富莱生物技术投资有限公司 一种以苯甲酸和有机酸防腐剂相联合作为有效成分的组合物及其用途
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
RU2444370C1 (ru) * 2010-06-30 2012-03-10 Владимир Александрович Мельников Пребиотик, стимулирующий рост вагинальной лактофлоры
US9011909B2 (en) * 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
WO2015135470A1 (zh) 2014-03-13 2015-09-17 曾忠铭 一种阴道用组合物与该组合物的用途
RU2563232C1 (ru) * 2014-04-01 2015-09-20 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ получения лечебного гидрогеля
US10016361B2 (en) 2014-10-24 2018-07-10 Francoise Farron PH change in the vagina as a contraceptive
CN105055439B (zh) * 2015-08-21 2018-04-13 叶元康 一种阴道微生态维护、保健和防治制剂及制备方法与应用
US20180256615A1 (en) * 2015-09-29 2018-09-13 Kimberly-Clark Worldwide, Inc. Composition for maintaining lactobacillus dominance
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
EP3442501A1 (de) 2016-04-15 2019-02-20 Fairhaven Health, LLC Zusammensetzungen und verfahren zur aufrechterhaltung oder erhöhung der homöostase oder funktion des unteren weiblichen fortpflanzungstraktes
EP3272333A1 (de) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginale zubereitung enthaltend eine kombination von östrogen und vitamin d
CN107661502A (zh) * 2016-07-27 2018-02-06 厦门恩成制药有限公司 低聚糖在药物制剂中的应用
AU2017401761B2 (en) 2017-02-28 2023-08-31 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
US12011469B2 (en) * 2017-05-23 2024-06-18 Vireo Systems, Inc. Parenteral delivery device and methods of use
MX2020006170A (es) * 2017-12-18 2020-11-24 Ansella Therapeutics Inc Composiciones y metodos para prevenir y tratar afecciones.
TWI754126B (zh) * 2018-07-19 2022-02-01 大江生醫股份有限公司 益生質組合物用於改善女性陰道內的菌相的用途及外用衛生用品
AU2019397458A1 (en) * 2018-12-11 2021-06-17 Glyciome, Llc Topical, isotonic compositions for genital use
CN109646394A (zh) * 2019-01-16 2019-04-19 江西鼎中科技有限公司 一种治疗细菌性阴道炎的蔗糖凝胶及其应用
RU2703260C1 (ru) * 2019-06-11 2019-10-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) Способ дифференцированной коррекции биоценоза влагалища при цервиковагинальных инфекциях у женщин в i триместре беременности
US12083304B2 (en) 2019-12-23 2024-09-10 Glyciome, Llc Kits for topical, isotonic compositions
EP4081664A4 (de) * 2019-12-23 2024-01-10 Glyciome, LLC Mikrobiomoptimierung
CN111175103B (zh) * 2020-01-16 2023-07-04 江西业力医疗器械有限公司 一种真菌性阴道炎荧光检测的白带样本前处理液及其制备方法
WO2021250019A1 (de) * 2020-06-09 2021-12-16 G. Pohl-Boskamp Gmbh & Co. Kg Zusammensetzungen zur prophylaxe und behandlung von harnwegsinfektionen und zur kosmetischen anwendung
WO2022006205A1 (en) 2020-06-30 2022-01-06 Vireo Systems, Inc. Compositions and methods for treatment of vaginal infections
GB202018068D0 (en) * 2020-11-17 2020-12-30 Ucl Business Ltd Pharmaceutical composition
CN114306108A (zh) * 2022-01-17 2022-04-12 北京图灵微研生物科技有限公司 一种平衡妇科微生态菌群结构的护理剂
CN115006697A (zh) * 2022-05-14 2022-09-06 河南沃迈生物科技有限公司 一种医用妇科凝胶敷料微生态制剂装置及制作方法
CN118615324B (zh) * 2024-08-09 2024-11-15 山东第二医科大学 一种重塑阴道微环境和优化菌群结构的罗伊氏乳杆菌囊泡妇科凝胶剂及其制备方法和应用
CN119431516A (zh) * 2024-11-11 2025-02-14 北京旺江生物技术有限公司 一种阴道菌群修复液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
AU7176994A (en) * 1993-06-25 1995-01-17 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
AU1854297A (en) * 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal disorder compositions comprising substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
DE69831878D1 (de) 1997-11-24 2006-02-23 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
WO2001066084A2 (en) * 2000-03-07 2001-09-13 Rush-Presbyterian-St. Luke's Medical Center Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US20040192598A1 (en) * 2000-10-11 2004-09-30 Laura Kragie Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections

Also Published As

Publication number Publication date
CA2609754C (en) 2012-01-10
EP1911454B1 (de) 2012-01-11
RU2007143977A (ru) 2009-06-10
EP1911454A4 (de) 2009-07-29
WO2006114061A1 (en) 2006-11-02
US20120263667A1 (en) 2012-10-18
BRPI0612968A2 (pt) 2010-12-14
JP2008539176A (ja) 2008-11-13
RU2409368C2 (ru) 2011-01-20
CN101175503B (zh) 2012-12-12
CN101175503A (zh) 2008-05-07
JP5065246B2 (ja) 2012-10-31
US20080193428A1 (en) 2008-08-14
EP1911454A1 (de) 2008-04-16
CA2609754A1 (en) 2006-11-02
US8586549B2 (en) 2013-11-19

Similar Documents

Publication Publication Date Title
ATE540684T1 (de) Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina
DE60231007D1 (de) Antiseptische zusammensetzungen und verfahren
BR0108734A (pt) Composições antimicrobiais ácidas para tratar alimento e superfìcies de contato do alimento e métodos para uso das mesmas
WO2010033800A3 (en) Stable tetracycline aqueous formulations
ATE372124T1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
UA81568C2 (en) Benzoyl-substituted phenylalanine amides, methods and intermediate products for the production thereof, herbicidal composition and method for controlling undesired plants
WO2007089473A3 (en) Thickened fluid composition comprising chlorine dioxide
WO2007081978A3 (en) Modulators of hepatocyte growth factor / c-met activity
MX2009005413A (es) Formas cristalinas del acido zoledronico.
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
UA102236C2 (uk) Похідні еритропоетин-міметичного пептиду та їх фармацевтичні солі, їх одержання і застосування
ATE493452T1 (de) Verfahren zur herstellung von lösungsmittelhaltigem polyurethan
BRPI0803568B8 (pt) composição mucoaderente
EP1458870A4 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON siRNA, AMPHIPATISCHE VERBINDUNGEN UND POLYKATIONEN
NZ599377A (en) Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation
MX2007006861A (es) Composiciones que tienen alta eficacia antiviral y antibacterial.
WO2007018622A3 (en) Vaginal treatment composition
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
HRP20050786B1 (hr) Lokalna primjena fluorokinolina u lijeäśenju bakterijskih oboljenja dišnih organa
TW200613279A (en) New pesticides
HU0401170D0 (en) New pharmaceutical composition and process for producing it
PL1855692T3 (pl) Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy